$NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NAVIDEA BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NAVIDEA BIOPHARMACEUTICALS, INC. for free.

CIK Number: 0000810509
IRS Number: 311080091
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NAVB
Company Address: 4995 BRADENTON AVENUE SUITE 240 DUBLIN 43017
Phone number: 6147937500
Former name: NEOPROBE CORP, date of change: 1994-07-14

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Market Capitalization: $77.59M
Prev close: $0.52
Average Daily Volume: 833,077
Days Low: $0.49
Year Low: $0.26
Year High: $1.51

NAVIDEA BIOPHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Cutler Adam D.Director7,5003,900shares bought: 52,500 / shares sold: 0 STRONG BUYFeb 07 202010 days ago
RICE YEHUDA MICHAELDirector10,0005,200shares bought: 376,500 / shares sold: -28,000 STRONG BUYFeb 07 202010 days ago
Rosol Michael StanleyChief Medical Officer00Feb 07 202010 days ago
Rouan Sarah KathrynDirector10,8505,642shares bought: 55,850 / shares sold: 0 STRONG BUYFeb 07 202010 days ago
Scott John K Jr.10% Owner5,668,6332,947,689shares bought: 8,912,698 / shares sold: 0 STRONG BUYDec 11 20192 months ago

View all NAVIDEA BIOPHARMACEUTICALS, INC. insiders.

NAVIDEA BIOPHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...Rosol Michael StanleyChief Medical Offic ...Option ExerciseA1.0625,00026,50031,250
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorOption ExerciseA1.062,5002,6507,500
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorGrantA0.002,500310,8508.4 K to 10.9 K (+29.94 %)
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorOption ExerciseA1.062,5002,65010,000
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGrantA0.002,500310,0007.5 K to 10 K (+33.33 %)
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...Cutler Adam D.DirectorOption ExerciseA1.062,5002,6507,500
Feb 07 2020NAVBNAVIDEA BIOPHARMAC ...Cutler Adam D.DirectorGrantA0.002,50037,5005 K to 7.5 K (+50.00 %)
Dec 11 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.90555,555500,0005,668,6335.1 M to 5.7 M (+10.87 %)
Jun 21 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.754,000,0003,000,0005,113,0781.1 M to 5.1 M (+359.36 %)
Jun 21 2019NAVBNAVIDEA BIOPHARMAC ...Scott John K Jr.10% OwnerBuyP0.754,000,0003,000,0005,113,0781.1 M to 5.1 M (+359.36 %)
Jun 07 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.261,0001,25812,95012 K to 13 K (+8.37 %)
May 21 2019NAVBNAVIDEA BIOPHARMAC ...Rouan Sarah KathrynDirectorBuyP1.463,3504,9048,3505 K to 8.4 K (+67.00 %)
May 17 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.461,0001,46311,95011 K to 12 K (+9.13 %)
May 17 2019NAVBNAVIDEA BIOPHARMAC ...Latkin JedCEO, COO & CFOBuyP1.451,5002,18010,9509.5 K to 11 K (+15.87 %)
May 15 2019NAVBNAVIDEA BIOPHARMAC ...Bruck ClaudineDirectorBuyP1.902,5504,8557,5505 K to 7.6 K (+51.00 %)

View all NAVIDEA BIOPHARMACEUTICALS, INC. insider transactions.